Clinical Trial of Chinese Herbal Medicine for Idiopathic Pulmonary Fibrosis (IPF)
The Effectiveness of an Empirical Chinese Medicine Formulation for Idiopathic Pulmonary Fibrosis: an Open Label Clinical Trial
Sponsor: Queen Mary Hospital, Hong Kong
Terminated
Difficulty in recruiting eligible patients
Other terminated trials from Queen Mary Hospital, Hong Kong
Other Idiopathic Pulmonary Fibrosis trials with similar outcome
Listed as NCT03274544, this NA trial focuses on Idiopathic Pulmonary Fibrosis and remains terminated or withdrawn. Sponsored by Queen Mary Hospital, Hong Kong, it has been updated 8 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
May 2021 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Apr 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Nov 2018 — Apr 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
-
Oct 2017 — Jun 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Queen Mary Hospital, Hong Kong
- The University of Hong Kong
For direct contact, visit the study record on ClinicalTrials.gov .